Skip to content
knowrare
HealthSignal
Your condition community

Living with Ornithine carbamoyltransferase deficiency

An inherited condition in which too much ammonia builds up in the blood and affects the nervous system.

Understanding Ornithine carbamoyltransferase deficiency

Ornithine carbamoyltransferase (OTC) deficiency is a genetic disease that causes too much ammonia to build up in the blood.

Ammonia is toxic at high levels and especially affects the nervous system. Signs include lack of energy and appetite, trouble controlling breathing rate and body temperature, unusual movements, seizures, or coma. This form occurs in both males and females. GARD lists onset as any time in life.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Lack of energy (lethargy) and drowsiness
  • Poor appetite and poor suck
  • Seizures
  • Low body temperature
  • Low muscle tone
  • Avoiding protein foods

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include brain and nervous system specialists and genetic specialists.

  3. Consider genetic testing

    Changes in OTC are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

Care & treatment

Care team
Brain and nervous system specialists (neurologists); Genetic specialists (geneticists)
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with National Urea Cycle Disorders Foundation
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
What are the warning signs of high ammonia, and when should I seek urgent care?
Which diet plan and medicines help manage ammonia levels?
Would OTC genetic testing help my relatives?

Quick facts

Symptoms usually startany time in life
InheritanceX-Linked
GenesOTC

Changes in the OTC gene cause this condition. It is inherited in an X-linked way.

GeneticNeurologicalInherited Metabolic

Also known as: deficiency of citrulline phosphorylase; deficiency of ornithine carbamoyltransferase; deficiency of ornithine transcarbamylase; oct (ornithine carbamoyltransferase) deficiency; oct deficiency; ornithine carbamoyltransferase deficiency disease

Patient organizations

Source: NIH GARD · Ornithine carbamoyltransferase deficiencyGARD ID 8391 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Ornithine carbamoyltransferase deficiency.

Explore the Ornithine carbamoyltransferase deficiency blog

Explore research for Ornithine carbamoyltransferase deficiency

Explore actively recruiting Ornithine carbamoyltransferase deficiency studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Ornithine carbamoyltransferase deficiency with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Ornithine carbamoyltransferase deficiency studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Ornithine carbamoyltransferase deficiency

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Ornithine carbamoyltransferase deficiency

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Ornithine carbamoyltransferase deficiency experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.